help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 25, 2005
Endocrinology, doi:10.1210/en.2005-0781
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/12/5321    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fink, M.
Right arrow Articles by Rozman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fink, M.
Right arrow Articles by Rozman, D.

Submitted on June 27, 2005
Accepted on August 19, 2005

CHOLESTEROGENIC LANOSTEROL 14{alpha}-DEMETHYLASE (CYP51) IS AN IMMEDIATE EARLY RESPONSE GENE

Martina Fink, Jure Acimovic, Tadeja Rezen, Natasa Tansek, and Damjana Rozman*

Medical Center for Molecular Biology, Vrazov trg 2, Center for Functional Genomics and Bio-Chips, Zaloska 4, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia

* To whom correspondence should be addressed. E-mail: damjana.rozman{at}mf.uni-lj.si.

Lanosterol 14{alpha}-demethylase (CYP51) responds to cholesterol feedback regulation through sterol regulatory element binding proteins (SREBPs). The proximal promoter of CYP51 contains a conserved region with clustered regulatory elements: GC box, cAMP-response elements (CRE-like) and sterol regulatory element (SRE). In lipid-rich (SREBP-poor) conditions the CYP51 mRNA drops gradually, the promoter activity is diminished and no DNA-protein complex is observed at the CYP51-SRE1 site. The majority of cAMP-dependent transactivation is mediated through a single CRE (CYP51-CRE2). Exposure of JEG-3 cells to forskolin, a mediator of the cAMP-dependent signaling pathway, provokes an immediate early response of CYP51, which has not been described before for any cholesterogenic gene. The CYP51 mRNA increases up to 4-fold in 2 h and drops to basal level after 4 h. The inducible cAMP early repressor ICER is involved in attenuation of transcription. Overexpressed CREB/CREM transactivate the mouse/human CYP51 promoters containing CYP51-CRE2 independently of SREBPs and ICER decreases the CREB-induced transcription. Besides the increased CYP51 mRNA, forskolin affects the de novo sterol biosynthesis in JEG-3 cells. An increased consumption of lanosterol, a substrate of CYP51, is observed together with modulation of the post-lanosterol cholesterogenesis, indicating that cAMP-dependent stimuli cross-talk with cholesterol feedback regulation. CRE-2 is essential for cAMP-dependent transactivation while SRE seems to be less important. Interestingly, when CREB is not limiting, the increasing amounts of SREBP-1a fail to transactivate the CYP51 promoter above the CREB-only level, suggesting that hormones might have an important role in regulating cholesterogenesis in vivo.


Key words: cytochrome P450 • CYP51 • cholesterol biosynthesis • immediate early response gene • cAMP • expression







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society